====== Jill Glasspool-Malone ======

{{ ::jill_glasspool-malone.jpeg?200|}}

**Jill Glasspool-Malone** is an American biotechnology researcher and entrepreneur. She is married to [[Robert Malone]].

===== History =====

==== Education ====

Glasspool-Malone studied anthropology at the [[University of California San Diego]] from September 1986 - June 1989, with an emphasis on behaviour.((//Jill Glasspool Malone.// ResearchGate. Retrieved March 4, 2023, from https://archive.ph/Z5Pgx)) She then studied Comparative Pathology at the [[University of California Davis]] from September 1994 - December 1996. 

==== Career ====

In January 1997, she started work as a research specialist at the [[University of Baltimore]], acting as a Biosecurity Level 2 (BSL-2) laboratory manager and supervisor. Her duties included managing the lab's regulatory needs, budgeting, grant writing, and writing papers for publication on the topics of [[immunology]], [[cell culture]], [[gene transfer]], and [[genetic vaccination]]. She remained in this position until August 2000.

=== Intradigm ===

Glasspool-Malone co-founded [[pharmaceutical_companies:Intradigm]], a [[gene therapy]] and targeted drug delivery company in [[united_states:maryland:Rockville]], [[united_states:Maryland]]. She began working on the startup in August 1999 as Managing Director, helping to secure $2.3 million in venture capital funding, setting up laboratory and office facilities, and developing the company's scientific and business development plan.((//Jill Glasspool Malone.// ResearchGate. Retrieved March 4, 2023, from https://archive.ph/Z5Pgx)) Intradigm launched in mid-2000.((Bodnar, T. (2002). //Venture Capital Funds Annual Report July 2002 (p. 27).// Maryland Department of Business & Economic Development. https://web.archive.org/web/20230304190817/https://msa.maryland.gov/megafile/msa/speccol/sc5300/sc5339/000113/000000/000115/unrestricted/20030190e.pdf))

=== Gene Delivery Alliance ===

On April 19, 2001, Glasspool-Malone founded the [[pharmaceutical_companies:Gene Delivery Alliance]], and became CEO of [[Robert Malone MD, LLC]] in August 2001.((Delaware Department of State Division of Corporations. (2019, August 19). //GENE DELIVERY ALLIANCE, INC.// OpenCorporates. https://archive.ph/ve1EU)) From September 2001 to June 2005, she studied Public Policy at the [[Union Institute & University]] with a specialization in biotechnology.

In 2002, she published a paper titled //[[https://www.sciencedirect.com/science/article/abs/pii/S0076687902460491|Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields]]// with [[Robert Malone]] on which she lists Gene Delivery Alliance as her affiliation.((Glasspool-Malone, J., & Malone, R. W. (2002). //[4] Enhancing direct in vivo transfection with nuclease inhibitors and pulsed electrical fields.// Methods in Enzymology, 72–91. [[https://www.sciencedirect.com/science/article/abs/pii/S0076687902460491|https://doi.org/10.1016/s0076-6879(02)46049-1]]))

She and Robert both received postgraduate training as a [[Harvard Medical School]] Global Clinical Scholar in 2015-2016.((//Dr. Jill Glasspool | Atheric Pharmaceutical | United States of America.// OMICS International. Retrieved March 5, 2023, from http://archive.today/2023.03.05-034708/https://biography.omicsonline.org/united-states-of-america/atheric-pharmaceutical/dr-jill-glasspool-524863))

=== COVID-19 ===

{{ ::screenshot_2023-03-04_at_10.27.54_pm.png?400|}}

On May 17, 2021, Glasspool-Malone posted two back-to-back comments on an [[IPWatchdog]] article titled "The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I". The first comment read, "Robert Malone and I have a patent that included RNA vaccination, which expired in 2017, but it is interesting because many of the patents listed above and issued prior to 2017 – claim nasal and mucosal routes." She included the patent, titled "[[https://archive.ph/y6YEh|DNA vaccines for eliciting a mucosal immune response]]", assigned to the [[University of Maryland]]. The second comment, posted only four minutes later, read, "As Robert Malone clearly invented mRNA vaccines while at the Salk and Vical, it is interesting that there is not mention of his work?" followed by a series of publications and patents.((Shores, D., Haversack, D., & Storaska, A. J. (2021, April 11). //The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic –Part I.// IPWatchdog. http://archive.today/2023.03.04-185835/https://ipwatchdog.com/2021/04/11/mrna-ip-competitive-landscape-one-year-covid-19-pandemic-part/id=132130/))

In June 2021, Glasspool-Malone published a short essay titled "A Scientific Education: The Early Discoveries of RNA and DNA Vaccination" in which she articulated her perspective on Malone's career as it relates to the invention of [[mRNA vaccines]] and [[DNA vaccines]].((Glasspool-Malone, J. (2021, June). //A Scientific Education: The Early Discoveries of RNA and DNA Vaccination.// Squarespace. https://web.archive.org/web/20230120032719/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/60b62e4f1dcb1f52ad2d4c0c/1622552143483/Jill%27s+letter+about+RNA+vaccination+generic+v5+June2021.pdf))

===== Publications =====

==== Patents ====

  * [[https://patents.google.com/patent/WO2003013615A1/en|Electroporative delivery of molecules to organs]]
  * May 24, 1996: [[https://archive.ph/y6YEh|DNA vaccines for eliciting a mucosal immune response]]

==== Studies ====

  * March 28, 2002: [[https://onlinelibrary.wiley.com/doi/abs/10.1002/jgm.259|DNA transfection of macaque and murine respiratory tissue is greatly enhanced by use of a nuclease inhibitor]]

===== External links =====

  * [[https://sites.google.com/housatonicits.com/home0004/research/jill-glasspool-malone-b1960|Housatonic]]